Streetbeat News

Revenues

DIA

IWM

QQQ

SPY

TSM

Major indexes rose due to strong performance in chip stocks after TSM's earnings, an ECB rate cut, and better-than-expected US retail sales.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 1:49 pm

CNPOF

CNTMF

RIV Capital has partnered with cannabis wholesale platform Nabis to enhance distribution in New York. This partnership aims to expand RIV's reach and efficiency in the growing New York cannabis market. The merger with Cansortium is also expected to boost RIV's market presence.

Portfolio Pulse from Nina Zdinjak

October 17, 2024 | 1:37 pm

TSM

XRT

The European Central Bank (ECB) has cut interest rates, which is a significant monetary policy move. Chip stocks have gained following strong guidance from Taiwan Semiconductor Manufacturing Company (TSM). Additionally, September retail sales have exceeded estimates, indicating robust consumer spending.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 1:36 pm

TVGN

Tevogen Bio Oncology projects $1 billion in revenue for its launch year and $10-$14 billion over five years, driven by its treatment for SARS-CoV-2 in cancer patients. The company also plans to expand into additional therapeutic areas and has long-term innovation goals.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 1:34 pm

RENB

RenovaroCube has presented new research on non-invasive cancer diagnostics using Oxford Nanopore sequencing at the Molecular Analysis for Precision Oncology Congress. The study focuses on detecting copy number alterations in lung cancer patients using cfDNA from blood plasma.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 1:32 pm

ADN

Advent Technologies has announced a significant breakthrough in MEA technology, achieving 2.5 times the power density of traditional HT-PEM systems. The company aims to target commercial-scale applications by 2025, focusing on green fuels and reducing costs below $0.1/kWh for fuel cell systems.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 1:32 pm

MET

MetLife Inc. (NYSE:MET) is trading at $85.60, with a 0.49% increase in the current session. Over the past month, the stock rose by 5.77%, and by 42.66% over the past year. Its P/E ratio of 23.15 is higher than the insurance industry average of 18.7, suggesting potential overvaluation or expected future performance.

Portfolio Pulse from Benzinga Insights

October 17, 2024 | 1:30 pm

INFY

Infosys (NYSE:INFY) has raised its FY2025 sales outlook, expecting revenue to increase by 3.75%-4.50% in constant currency. The new sales forecast is between $19.26 billion and $19.40 billion, up from the previous range of $19.12 billion to $19.30 billion.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 1:30 pm

TOMZ

TOMI Environmental Solutions reported a record Q3 2024 iHP Corporate Service revenue of $650K, driven by increased demand in the life sciences sector. The company has secured multi-year contracts with MD Anderson, Pfizer, and LFB USA, indicating potential continued growth in disinfection services.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 1:27 pm

EQX

Equinox Gold Corp. (AMEX:EQX) shares fell premarket after the company lowered its 2024 production guidance for the Greenstone Gold Mine. Despite a significant increase in Q3 production, the company revised its guidance from 175,000-205,000 ounces to 110,000-130,000 ounces. The company is focused on ramping up mining rates and plant throughput to achieve design capacity.

Portfolio Pulse from Lekha Gupta

October 17, 2024 | 1:23 pm